Research Achievements
Research conducted through the Endometrial Cancer Consortium won two international awards for best clinical presentations at the 2023 and 2022 meetings of the Society of Gynecology Oncology (SGO). Highlights include: Dr. Secord was installed as president of the SGO at its 2023 annual meeting. She received the Best Clinical Science Award for the abstract titled “Genomic Alterations, Molecularly Targeted Therapy and Race: Real World Data from the Endometrial Cancer Molecularly Targeted Therapy Consortium.”
Additional Awards
Clinical Outcomes of Patients with High Tumor Mutational Burden, High Microsatellite Stability, and Mismatch Repair Deficiency in a Multi-Institutional Endometrial Cancer Consortium
- Oral presentation at SGO 2023, March 25-28, 2023. Manuscript in development.
- Molecular Classification of Endometrial Cancers (EC) and Association with Relapsle-Free Survival Outcomes: Ancillary Analysis of GOG-0258
- Oral Plenary at the 2023 Annual Global Meeting in Seoul, Republic of Korea
- Differential Genomic Alterations in TP53-Mutated Endometrial Cancers and Associations with Race and Survival Outcomes
- Awarded Best Clinical Practice Abstract 2022 at SGO, March 18-21, 2022.
- Differential Genomic Alterations in TP53-Mutated Endometrial Cancers and Associations with Race and Survival Outcomes
- Awarded SGO Winter Meeting Best Oral Abstract Presentation 2023 at SGO Winter meeting, Feb. 2-4, 2023.
- Abstracts and presentations continue to be submitted and accepted.